BHMT Antibody (C-term) Blocking peptide
Synthetic peptide
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | Q93088 |
---|---|
Other Accession | NP_001704.2 |
Clone Names | 90826083 |
Gene ID | 635 |
---|---|
Other Names | Betaine--homocysteine S-methyltransferase 1, BHMT |
Format | Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed. |
Storage | Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C. |
Precautions | This product is for research use only. Not for use in diagnostic or therapeutic procedures. |
Name | BHMT {ECO:0000303|PubMed:8798461} |
---|---|
Function | Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline. |
Cellular Location | Cytoplasm, cytosol {ECO:0000250|UniProtKB:O09171}. Nucleus {ECO:0000250|UniProtKB:O09171} Note=Predominantly localized in the cytoplasm with a small fraction detected in the nucleus. Translocates into the nucleus upon oxidative stress. {ECO:0000250|UniProtKB:O09171} |
Tissue Location | Found exclusively in liver and kidney. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
This gene encodes a cytosolic enzyme that catalyzes theconversion of betaine and homocysteine to dimethylglycine andmethionine, respectively. Defects in this gene could lead tohyperhomocyst(e)inemia, but such a defect has not yet beenobserved.
References
Bailey, S.D., et al. Diabetes Care 33(10):2250-2253(2010)Giusti, B., et al. Thromb. Haemost. 104(2):231-242(2010)Hobbs, C.A., et al. Obstet Gynecol 116 (2 PT 1), 316-322 (2010) :Liu, C.Y., et al. Carcinogenesis 31(7):1259-1263(2010)Jugessur, A., et al. PLoS ONE 5 (7), E11493 (2010) :
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.